GPC6 and Alzheimer disease: Follow-up analyses in autopsied EUR AD cases and controls from the ROSMAP study [81] showed that ALCAM, ARAP1, GPC6, and RBFOX1 expression in the brain was associated with amyloid load, and STARD10 expression was associated with Tau pathology.